The CEO of GSK (formerly GlaxoSmithKline), Dame Emma Walmsley, joins hosts Omar Abbosh and will.i.am to discuss how innovation and biotechnology are changing the future of medicine. GSK has a history of discovering game-changing medical therapies, from pharmaceuticals to consumer healthcare products. Now the global company is spinning off its consumer product business into an independent company, allowing GSK to focus fully on drug development and vaccines.

Read the transcript

Hosted on Acast. See acast.com/privacy for more information.